Needham & Company LLC Downgrades Inozyme Pharma (NASDAQ:INZY) to Hold
Inozyme Pharma (NASDAQ:INZY – Get Free Report) was downgraded by analysts at Needham & Company LLC from a “moderate buy” rating to a “hold” rating in a report issued on Friday,Zacks.com reports. A number of other research analysts have also weighed in on the company. Jefferies Financial Group restated a “hold” rating and issued a […]
Inozyme Pharma (NASDAQ:INZY – Get Free Report) was downgraded by analysts at Needham & Company LLC from a “moderate buy” rating to a “hold” rating in a report issued on Friday,Zacks.com reports. A number of other research analysts have also weighed in on the company. Jefferies Financial Group restated a “hold” rating and issued a […]
